FDA-rejected Merck med gets E.U. approval

Merck's cholesterol drug Tredaptive received approval in the European Union, Iceland, and Norway, clearing the way for marketing in 29 nations; formerly known as Cordaptive, it was rejected by the FDA earlier this year. Report

Suggested Articles

Pfizer isn't giving up in biosims. This week, it unveiled launches to three Roche blockbusters, with two already on the market.

Tecentriq didn’t show benefit against simple observation at delaying cancer recurrence or death in patients with muscle-invasive urothelial cancer.

Patients with epithelioid sarcoma previously had no targeted treatment options, but that'll change with Epizyme's approval for Tazverik.